Optic Neuropathy Clinical Trial
Official title:
Neuromuscular Ultrasonography Assessment of Optic Nerve in SLE
NCT number | NCT05853003 |
Other study ID # | bending |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | January 1, 2022 |
Est. completion date | April 30, 2023 |
Verified date | July 2023 |
Source | Assiut University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
assessing the role of neuromuscular ultrasound in optic nerve involvement in systemic lupus patients.
Status | Completed |
Enrollment | 140 |
Est. completion date | April 30, 2023 |
Est. primary completion date | December 31, 2022 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 17 Years and older |
Eligibility | Inclusion Criteria: - Adult - group of SLE patients, who fulfilled Systemic Lupus International Collaborating Clinics classification criteria for SLE (SLICC) with or without symptoms of optic neuropathy - another group of apparently healthy subjects with no. history of chronic conditions Exclusion Criteria: - Any patient with optic neuritis due to causes other than lupus was excluded from the study: ex. - Post traumatic neuropathy - Purely degenerative neuropathy - Diabetic neuropathy - Toxic neuropathy - Neuropathies related to infections - Drug induced neuropathy e.g: quinine and some antibiotics, ethambutol - Infections e.g. measles, mumps, Lyme disease, etc. - Other Autoimmune diseases like sarcoidosis, B.D - Tumor causing Inc. intracranial tension. |
Country | Name | City | State |
---|---|---|---|
Egypt | Assuit university hospital | Assiut |
Lead Sponsor | Collaborator |
---|---|
Amira M elSonbaty |
Egypt,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | comparing diameter (in mm2) of optic nerve in SLE patients and compare them to healthy subjects | comparing diameter (in mm2) of optic nerve in SLE patients and compare them to healthy subjects | over 1 year |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT02982499 -
Biomechanics of Optic Neuropathy
|
||
Recruiting |
NCT05543018 -
Effect of Intraocular Tamponade on Visual Perception
|
N/A | |
Completed |
NCT03318549 -
BCI and Evaluation of Visual and Task Performance in Subjects With Eye Diseases
|
N/A | |
Terminated |
NCT03536559 -
Nanocrystalline Gold to Treat Remyelination Failure in Chronic Optic Neuropathy In Multiple Sclerosis
|
Phase 2 | |
Recruiting |
NCT06128720 -
Hyperbaric Oxygen Therapy for Optic Neuropathies
|
N/A | |
Withdrawn |
NCT01331616 -
Optic Neuropathy in 10 Patients With Glioblastoma Receiving Bevacizumab
|
Early Phase 1 | |
Not yet recruiting |
NCT05747781 -
STReetlab Assessment Tool of Activities Daily Living in Glaucoma Patient
|
N/A | |
Completed |
NCT01166594 -
Use of Bevacizumab in Trabeculectomy Surgery
|
Phase 4 | |
Completed |
NCT03268681 -
BIOtinidase Test In Optic-Neuropathy
|
||
Completed |
NCT02612571 -
Comparing Rates of Glaucoma in Professional Wind Versus Non-Wind Instrument Players
|
N/A | |
Recruiting |
NCT03011541 -
Stem Cell Ophthalmology Treatment Study II
|
N/A | |
Enrolling by invitation |
NCT03760055 -
Assessment of Visual Function With a Portable Brain-computer Interface
|
||
Recruiting |
NCT02638714 -
Treatment of Optic Neuropathies Using Autologous Bone Marrow-Derived Stem Cells
|
Phase 1/Phase 2 | |
Completed |
NCT04469777 -
Subcutaneous Injection of Erythropoietin on Visual Functions in Patients With Late Onset Optic Neuropathy
|
Phase 1/Phase 2 |